Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01KMY
|
|||
Former ID |
DNCL003822
|
|||
Drug Name |
MK-8342
|
|||
Indication | Contraception [ICD-11: QA21] | Phase 2 | [1] | |
Company |
Merck
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Progesterone receptor (PGR) | Target Info | Agonist | [2] |
KEGG Pathway | Oocyte meiosis | |||
Progesterone-mediated oocyte maturation | ||||
Pathway Interaction Database | Cellular roles of Anthrax toxin | |||
Reactome | Nuclear signaling by ERBB4 | |||
Nuclear Receptor transcription pathway | ||||
WikiPathways | Ovarian Infertility Genes | |||
Signaling by ERBB4 | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Merck (May 7, 2015). | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 627). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.